Clinician scientist receives RPB Career Development Award to support eye research

The Harvard Medical School (HMS) Department of Ophthalmology has been granted a $250,000 Research to Prevent Blindness (RPB) Career Development Award to support eye research conducted by Jason I. Comander, M.D., Ph.D. The support will be provided over a four-year period.

The RPB Career Development Award Fund was established in 1990 to attract young physicians and basic scientists to eye research. To date, the program has given awards to 174 vision research scientists in departments of ophthalmology at universities across the country.

Dr. Comander's current research efforts are focused on studying patients with inherited retinal degenerations, including retinitis pigmentosa (RP), which is caused by genetic mutations inherited from one or both parents. Most people who suffer from RP typically experience a steady visual decline during their lifetime, with many patients becoming blind. The disease affects approximately 100,000 people in the U.S. and 2 million people worldwide.

A clinician scientist, Dr. Comander is a member of the Retina Service and the Berman-Gund Laboratory for the Study of Retinal Degenerations at Mass. Eye and Ear. He also conducts research as a member of the Ocular Genomics Institute at Mass. Eye and Ear/Harvard Medical School. With support from the RPB grant, Dr. Comander intends to develop and apply techniques for high-throughput functional characterization of human genetic variation and mutation in retinitis pigmentosa.

"This research addresses a major challenge in understanding the mechanisms that underlie the pathology of inherited retinal disease, and will help us determine which gene misspellings in patients are disease-causing and which are benign," says Dr. Comander. "This is an important time in the field of inherited retinal degenerations, when early successes with gene therapy and molecular diagnostics need to be expanded and translated into broad clinical use."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research links COVID-19 vaccines to temporary facial palsy in over 5,000 patients